Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides

Details for Australian Patent Application No. 2004263265 (hide)

Owner Novartis AG

Inventors Sedelmeier, Gottfried

Agent Davies Collison Cave

Pub. Number AU-B-2004263265

PCT Pub. Number WO2005/014602

Priority 0316546.1 15.07.03 GB

Filing date 15 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 6 September 2007

International Classifications

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07F 5/02 (2006.01) Compounds containing elements of the 3rd Group of the Periodic System

C07F 5/06 (2006.01) Compounds containing elements of the 3rd Group of the Periodic System

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014602 Priority application(s): WO2005/014602

6 September 2007 Application Accepted

  Published as AU-B-2004263265

10 January 2008 Standard Patent Sealed

22 May 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 11 Mar 2008. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2005

25 September 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 11 Mar 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263268-Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors

2004263258-Anaqueous solution of a sodium salt of HEDTA